Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 ,inter alia, to consider and approve the unaudited standalone ....
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jubilant Pharmova has informed the stock exchanges that its Board of Directors will meet on Friday, October 31, 2025. The meeting will, among other things, consider and approve the unaudited standalone and consolidated financial results of the company for the quarter and half year ended September 30, 2025 (Q2FY26 and H1FY26). The filing is a standard regulatory intimation under SEBI Listing Regulations and does not contain any financial numbers or outcomes. The signed communication was issued by Naresh Kapoor, Company Secretary, on October 14, 2025.
This is a routine advance notice ahead of the Q2FY26 earnings release. No direct impact on shareholders or the stock price; investors should await the actual results on or after October 31 for any meaningful insight into revenue, margins, and profits.